Stallion India Fluorochemicals Limited has announced robust financial results for the quarter ended September 30. The company's Board of Directors convened on October 13 to review and approve the financial statements.

Financial Highlights

• Revenue increased to 1.06 billion rupees from 676.00 million rupees year-over-year, marking a 57% growth
• Net profit surged significantly to 114.00 million rupees compared to 8.50 million rupees in the same period last year
• EBITDA jumped to 156.00 million rupees from 19.00 million rupees year-over-year
• EBITDA margin expanded substantially to 14.75% from 2.88% in the previous year

Board Meeting Details

The board meeting, which commenced at 11:00 AM and concluded at 1:05 PM, addressed several key points:

• Approval of unaudited financial results for Q2 and H1
• Review of the Limited Review Report from statutory auditors

Auditor's Review

Mittal & Associates Chartered Accountants, the company's statutory auditors, provided a Limited Review Report on the financial results. The auditors stated that based on their review:

"Nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement."

Regulatory Compliance

Stallion India Fluorochemicals has affirmed its compliance with Regulations 30, 33, and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This ensures transparency and adherence to regulatory standards in financial reporting.

Conclusion

The approval of the unaudited financial results, coupled with the positive review from the statutory auditors, indicates that Stallion India Fluorochemicals Limited is maintaining its financial reporting obligations while demonstrating significant growth. The company's strong performance, particularly the substantial increase in revenue and net profit, reflects positively on its operational efficiency and market position.

The company continues to uphold its commitment to transparency and regulatory compliance, as evidenced by the timely conduct of its board meeting and the prompt disclosure of the meeting's outcome to the stock exchanges.

Stallion India Fluorochemicals Limited has taken a significant step towards expanding its manufacturing capabilities in the fluorochemicals sector. The company recently received approval for land allotment in Bhilwara, Rajasthan, to establish a new manufacturing plant.

Land Allotment Details

According to a regulatory filing dated August 29, 2025, Stallion India Fluorochemicals has been granted land allotment by RIICO (Rajasthan State Industrial Development and Investment Corporation), a Government of Rajasthan entity. The company has initiated the necessary formalities for registration and is in the process of taking physical possession of the allotted land.

Strategic Expansion

This development comes as part of Stallion India Fluorochemicals' strategic expansion plans in the fluorochemicals industry. The new manufacturing plant in Bhilwara represents a significant investment in the company's production capabilities, potentially enhancing its market position in the sector.

Government Collaboration

The land allotment follows a Memorandum of Understanding (MoU) executed between Stallion India Fluorochemicals and the Government of Rajasthan. This collaboration, initially disclosed on August 11, 2025, underscores the company's commitment to industrial growth in the region and aligns with the state government's efforts to attract investments.

Looking Ahead

While specific details about the plant's capacity, investment amount, and expected timeline for completion have not been disclosed, this land allotment marks a crucial first step in Stallion India Fluorochemicals' expansion project. The establishment of this new manufacturing facility is expected to strengthen the company's production capabilities and potentially create new employment opportunities in the Bhilwara region.

Investors and industry observers will likely keep a close watch on further developments regarding this new manufacturing plant, as it could have significant implications for Stallion India Fluorochemicals' future growth and market position in the fluorochemicals sector.